Mysten Labs

Mysten Labs does not operate as a traditional fund with an investment committee. Product and protocol development decisions are shaped by the five co-founders: Evan Cheng (CEO), Sam Blackshear (CTO), Adeniyi Abiodun (CPO), Kostas Chalkias (Chief Cryptographer), and George Danezis (Chief Scientist). Capital allocation for ecosystem grants and developer incentives is guided by the product roadmap rather than a standalone investment team.

It is neither a family office nor a venture firm. Mysten Labs is a core-infrastructure company that builds and governs the Sui blockchain. It raised venture capital in two rounds — a $36 million Series A in 2021 and a $300 million Series B in 2022 — which funds product development rather than a portfolio of external investments.

Mysten Labs does not make fund commitments or pursue financial deals in the traditional sense. Its capital flows into protocol development, ecosystem grants, and the creation of native products — such as the Walrus storage protocol and DeepBook order book — all built directly on Sui.

Mysten Labs has no publicly stated exclusion list, but its activity is tightly constrained to blockchain infrastructure and the Sui ecosystem. It does not allocate capital to public equities, real estate, private credit, hedge funds, or any asset class outside Sui's developer tooling and adoption campaigns.

Mysten Labs generates its own pipeline through Sui's grant programs, hackathons, and its network of venture backers — including a16z Crypto, Lightspeed Venture Partners, and Coinbase Ventures. The firm's concentration on the Move programming language and its Novo/Diem engineering pedigree give it a direct line to developers building parallel-execution smart contracts, a niche few other teams can credibly support.

There is no public evidence that Mysten Labs operates a philanthropic foundation or donor-advised fund. The firm's website and public filings do not mention any charitable vehicle separate from its protocol-building operations.

Mysten Labs does not co-invest as a limited partner alongside external GPs in the manner of a family office or institutional allocator. Third-party venture funds — such as those listed as investors in its own rounds — occasionally back Sui ecosystem projects independently, but Mysten Labs itself acts as a protocol sponsor and grant issuer rather than a syndicate participant.